+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Vitamin D Therapy Market by Route of Administration (Oral Route of Administration, Parenteral Route of Administration), Purchasing Pattern (Over-The-Counter Drugs, Prescription Drugs), Age Group, Indication - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829954
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Vitamin D Therapy Market size was estimated at USD 3.20 billion in 2023, USD 3.61 billion in 2024, and is expected to grow at a CAGR of 12.75% to reach USD 7.42 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vitamin D Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vitamin D Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vitamin D Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Amway Corp., Bayer AG, Bio-Tech Pharmacal, Inc., GlaxoSmithKline PLC, Healthy Body LLC, Merck KGaA, Otsuka Holdings Co., Ltd, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Superior Supplement Manufacturing, The Zydus group, and Vitablend Nederland B.V.

Market Segmentation & Coverage

This research report categorizes the Vitamin D Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Oral Route of Administration
    • Parenteral Route of Administration
  • Purchasing Pattern
    • Over-The-Counter Drugs
    • Prescription Drugs
  • Age Group
    • Adults
    • Children
  • Indication
    • Autoimmune Disorders
    • Muscle Weakness
    • Osteoporosis
    • Rickets
    • Skin Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Vitamin D Therapy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vitamin D Therapy Market?
  3. What are the technology trends and regulatory frameworks in the Vitamin D Therapy Market?
  4. What is the market share of the leading vendors in the Vitamin D Therapy Market?
  5. Which modes and strategic moves are suitable for entering the Vitamin D Therapy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Vitamin D Therapy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of vitamin D deficiency in the U.S.
5.1.1.2. Presence of a large target patient population
5.1.1.3. Growing awareness regarding vitamin D therapy
5.1.2. Restraints
5.1.2.1. Limited clinical Trials
5.1.3. Opportunities
5.1.3.1. Increasing growth opportunities in countries with a high prevalence of undernutrition
5.1.3.2. Rise in R&D activities for development of efficient vitamin D therapies
5.1.4. Challenges
5.1.4.1. Availability of fortified foods
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Vitamin D Therapy Market, by Route of Administration
6.1. Introduction
6.2. Oral Route of Administration
6.3. Parenteral Route of Administration
7. Vitamin D Therapy Market, by Purchasing Pattern
7.1. Introduction
7.2. Over-The-Counter Drugs
7.3. Prescription Drugs
8. Vitamin D Therapy Market, by Age Group
8.1. Introduction
8.2. Adults
8.3. Children
9. Vitamin D Therapy Market, by Indication
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Muscle Weakness
9.4. Osteoporosis
9.5. Rickets
9.6. Skin Diseases
10. Americas Vitamin D Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Vitamin D Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Vitamin D Therapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Alkem Laboratories Ltd.
14.1.3. Amway Corp.
14.1.4. Bayer AG
14.1.5. Bio-Tech Pharmacal, Inc.
14.1.6. GlaxoSmithKline PLC
14.1.7. Healthy Body LLC
14.1.8. Merck KGaA
14.1.9. Otsuka Holdings Co., Ltd
14.1.10. Pfizer Inc.
14.1.11. Sanofi S.A.
14.1.12. Sun Pharmaceutical Industries Ltd.
14.1.13. Superior Supplement Manufacturing
14.1.14. The Zydus group
14.1.15. Vitablend Nederland B.V.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. VITAMIN D THERAPY MARKET RESEARCH PROCESS
FIGURE 2. VITAMIN D THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VITAMIN D THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VITAMIN D THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VITAMIN D THERAPY MARKET DYNAMICS
FIGURE 7. VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 8. VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2030 (%)
FIGURE 10. VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 14. VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VITAMIN D THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VITAMIN D THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 6. VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 9. VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 12. VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 35. CANADA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. CANADA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 39. MEXICO VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 40. MEXICO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 57. CHINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. CHINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. INDIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 61. INDIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. INDIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 69. JAPAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. JAPAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 93. THAILAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. THAILAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. DENMARK VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 106. DENMARK VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. DENMARK VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 110. EGYPT VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. EGYPT VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 114. FINLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. FINLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 118. FRANCE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. FRANCE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 122. GERMANY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. GERMANY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 130. ITALY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. ITALY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 142. NORWAY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. NORWAY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. POLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 146. POLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. POLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. QATAR VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 150. QATAR VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. QATAR VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 166. SPAIN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. SPAIN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 178. TURKEY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. TURKEY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. VITAMIN D THERAPY MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amway Corp.
  • Bayer AG
  • Bio-Tech Pharmacal, Inc.
  • GlaxoSmithKline PLC
  • Healthy Body LLC
  • Merck KGaA
  • Otsuka Holdings Co., Ltd
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Superior Supplement Manufacturing
  • The Zydus group
  • Vitablend Nederland B.V.

Methodology

Loading
LOADING...

Table Information